Cannabigerol Recruiting Phase 4 Trials for Medication Overuse Headache / Chronic Migraine Treatment

Indications	Status	Purpose	Phase
DBCOND0042882 (Medication Overuse Headache) DBCOND0042084 (Chronic Migraine)	Recruiting	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT04989413	Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine -	Cannabidiol (DB09061) Cannabigerol (DB14734) Dronabinol (DB00470)